Global Parenteral Nutrition Market

Parenteral Nutrition Market Size, Share, Growth Analysis, By Consumer(Children and Newborns, and Adults), By End user(Clinics, Hospitals) - Industry Forecast 2024-2031


Report ID: SQMIG35C2022 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 62 | Figures: 75

Parenteral Nutrition Market Dynamics

Parenteral Nutrition Market Drivers

Technological Advancements in Parenteral Nutrition Products

  • The development of innovative formulations, improved nutrient combinations, and advanced delivery systems has enhanced the safety and efficacy of parenteral nutrition therapy. These advancements have made parenteral nutrition administration more convenient for healthcare providers and more tolerable for patients.

Increasing Awareness about Clinical Nutrition

  • There is a growing awareness of the importance of nutrition in overall health and disease management. This increased understanding of the role of nutrition in patient outcomes has led to a higher demand for parenteral nutrition therapy as a part of comprehensive healthcare.

Parenteral Nutrition Market Restraints

Regulatory Constraints and Lack of Standardization

  • Variations in regulations and lack of standardized guidelines for parenteral nutrition therapy across different regions pose challenges for manufacturers and healthcare providers. Harmonization of regulatory frameworks and the development of evidence-based guidelines are essential for ensuring safe and effective administration of parenteral nutrition.

Potential Complications and Limitations of Long-term Use

  • Prolonged dependence on parenteral nutrition may present complications such as liver dysfunction, fluid imbalances, and electrolyte abnormalities. These limitations and complications need to be carefully managed to ensure the optimal use of parenteral nutrition and minimize risks to patients.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Parenteral Nutrition Market size was valued at USD 6.33 Billion in 2021 and is poised to grow from USD 6.71 Billion in 2022 to USD 10.7 Billion by 2030, at a CAGR of 6.0% during the forecast period (2023-2030).

The parenteral nutrition market is highly competitive and characterized by the presence of several key players striving to capture a significant share of the market. These companies are continuously engaged in research and development activities to introduce innovative products and gain a competitive edge. The competitive landscape is shaped by factors such as product offerings, technological advancements, pricing strategies, distribution networks, and partnerships. Market players in the parenteral nutrition industry focus on expanding their product portfolios by introducing new formulations and customized solutions to cater to specific patient needs. 'Fresenius Kabi (Germany)', 'B. Braun Melsungen AG (Germany)', 'Baxter International Inc. (US)', 'Grifols SA (Spain)', 'Otsuka Pharmaceutical Co., Ltd. (Japan)', 'Pfizer Inc. (US)', 'Aculife Healthcare Pvt. Ltd. (India)', 'Vifor Pharma (Switzerland)', 'Sichuan Kelun Pharmaceutical Co., Ltd. (China)', 'ALLERGAN (Ireland)', 'Claris Lifesciences Limited (India)', 'Actavis plc (Ireland)', 'ABBOTT (US)', 'AstraZeneca (UK)', 'Medtronic (Ireland)', 'Beximco Pharmaceuticals Ltd. (Bangladesh)', 'Sichuan Luye Pharmaceutical Co., Ltd. (China)', 'ICU Medical, Inc. (US)', 'JW Pharmaceutical Corporation (South Korea)', 'Hospira, Inc. (US)'

The development of innovative formulations, improved nutrient combinations, and advanced delivery systems has enhanced the safety and efficacy of parenteral nutrition therapy. These advancements have made parenteral nutrition administration more convenient for healthcare providers and more tolerable for patients.

Integration of Digital Health Technologies: Digital health technologies, such as mobile applications, connected devices, and telehealth solutions, are being integrated into parenteral nutrition therapy. These technologies enable remote monitoring, real-time data collection, and improved communication between patients, caregivers, and healthcare providers, leading to better patient management and enhanced treatment outcomes.

The dominance of North America can be attributed to several factors, including the presence of well-established healthcare infrastructure, advanced medical technologies, and high healthcare expenditure. Additionally, the region has a high prevalence of chronic diseases, an aging population, and a strong focus on research and development activities, which contribute to the demand for parenteral nutrition therapies. Moreover, the presence of major pharmaceutical and healthcare companies in North America further strengthens its dominant position in the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Parenteral Nutrition Market

Product ID: SQMIG35C2022

$5,300
BUY NOW GET FREE SAMPLE